IA
COLL icon

IFG Advisory’s Collegium Pharmaceutical COLL Stock Holding History

IFG Advisory’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.05K Buy
+250
New +$8.54K ﹤0.01% 1864

Other funds holding COLL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

IFG Advisory's COLL Position: Q2 2026 in Review

IFG Advisory opened a new position in Collegium Pharmaceutical (COLL) in Q2 2026: 250 shares worth $9.05K. The stake represents ﹤0.01% of the portfolio and ranks #1864 among its holdings.

279 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

  • IFG Advisory held 250 shares of Collegium Pharmaceutical worth $9.05K as of Q2 2026.
  • Collegium Pharmaceutical was a new IFG Advisory position in Q2 2026.
  • Collegium Pharmaceutical made up ﹤0.01% of IFG Advisory's portfolio in Q2 2026, its #1864 holding.
  • 279 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on IFG Advisory's 13F filing for Q2 2026, filed 14 Aug 2026.